Actualités 17 avr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 30 avr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
Aktuell 07 mai 2024 UZH forscht an neuer Krebstherapie Forschende der Universität Zürich (UZH) entwickeln neue Krebstherapeutika. Die sogenannten Radiotheranostika sollen Tumore gleichzeitig lokalisie...
News 17 avr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Aktuell 03 avr 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
Aktuell 27 mar 2024 TissueLabs startet Biofabrikation in Bellinzona TissueLabs sichert sich 800'000 Dollar und eröffnet ein neues Zentrum für Biofabrikation in Bellinzona. Die Mittel dienen der Verbesserung der ei...
News 07 mai 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News 30 avr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 27 mar 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
News 22 jan 2024 Supercomputers help to reduce inequality The Federal Department of Foreign Affairs and the Swiss Federal Institute of Technology in Zurich have launched the International Computation and...
Aktuell 04 avr 2024 Indivi spannt mit Biogen zusammen Indivi und Biogen wollen bei der Entwicklung digitaler Biomarker für die Parkinson-Krankheit kooperieren. Dafür lizenziert der amerikanische Biot...
News 14 fév 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 06 sep 2023 ten23 health boosts sterile production capacity and introduces new quality control services Renowned for its expertise in sterile drug product manufacturing, Valais-based ten23 health is taking significant steps to expand its services an...
Aktuell 22 jan 2024 Superrechner sollen Ungleichheiten reduzieren Das Eidgenössische Departement für auswärtige Angelegenheiten und die Eidgenössische Technische Hochschule Zürich haben das International Computa...
News 04 avr 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...
News 07 aoû 2023 CDR-Life receives milestone payment CDR-Life has reached a second milestone linked to the development of its drug to combat an irreversible retinal disease. This entitles the biotec...
News 03 avr 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...